This content is machine translated State-of-the-art asthma - inhaled corticosteroids From ICS to inhalers to MART/AIR – what makes a difference? Asthma is a heterogeneous, multifactorial, chronic inflammatory disease of the airways, which is usually characterized by bronchial hyperresponsiveness and/or variable airway obstruction and can manifest itself clinically through respiratory symptoms… CME-Test
View Post 14 min This content is machine translated State-of-the-art asthma - inhaled corticosteroids From ICS to inhalers to MART/AIR – what makes a difference? Asthma is a heterogeneous, multifactorial, chronic inflammatory disease of the airways, which is usually characterized by bronchial hyperresponsiveness and/or variable airway obstruction and can manifest itself clinically through respiratory symptoms… CME-Test
View Post 4 min This content is machine translated Asthma-COPD-Overlap Coexisting disease entities instead of syndrome The concept of overlapping disease entities has changed and the term “asthma overlap syndrome” is no longer propagated. Patients who meet the diagnostic criteria for asthma and COPD should be…
View Post 6 min This content is machine translated Treatment of chronic obstructive pulmonary disease New concepts in COPD management There are some changes in the 2023 GOLD recommendations, one of which is the clear emphasis on dual bronchodilation (LABA/LAMA) [1]. For most COPD patients, starting treatment with a LABA/LAMA…
View Post 4 min This content is machine translated Difficult to treat asthma in adolescents Adherence and self-management insufficient About 10% of adolescent asthmatics have difficult-to-treat asthma. Poor adherence is a key problem in this age group and is largely responsible for poor symptom control. Early multidisciplinary management and…
View Post 5 min This content is machine translated COPD: Update for the primary care physician Counteract exacerbations and improve quality of life To achieve a reduction in the frequency of exacerbations – a primary therapeutic goal in COPD – a multimodal therapy concept is recommended. Regarding bronchodilator inhalation therapy, SABA and SAMA…
View Post 5 min This content is machine translated Severe asthma Many antibodies lead to success If asthma patients use an inhaled corticosteroid (ICS) over a longer period of time and in high doses, even the additional combination with a long-acting β2-agonist (LABA) does not respond…
View Post 5 min This content is machine translated Moderate asthma What drives the physician’s therapy decision When treating asthma patients, many thoughts run through the physician’s mind – after all, on the one hand he usually has several therapy options, but on the other hand he…
View Post 4 min This content is machine translated COPD treatment Fewer exacerbations with mucolytics Mucolytics are included in several guidelines as a treatment option for patients with frequent exacerbations. According to GOLD, they can reduce exacerbations and marginally improve health status. However, evidence is…
View Post 6 min This content is machine translated Asthma management Difficult or difficult to treat? Modern asthma therapy is phenotype-based. Long-term treatment goals are good symptom control and minimization of the risk of exacerbations. However, symptom control does not equate to asthma severity.
View Post 9 min This content is machine translated COPD "Chronic Obstructive Pulmonary Disease" Inhalation therapy – an overview Inhalation therapy for COPD is based on symptoms and exacerbation frequency. Basic therapy for COPD is based on long-acting bronchodilators. Inhaled corticosteroids are used only under certain conditions.
